Ravindra Shukla
Overview
Explore the profile of Ravindra Shukla including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
41
Citations
271
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Shamim M, Manna S, Dwivedi P, Swami M, Sahoo S, Shukla R, et al.
Medicine (Baltimore)
. 2023 Nov;
102(45):e35937.
PMID: 37960804
Background: Major depressive disorder is often resistant to first-line treatment, with around 30% failing to respond to traditional therapy. Treatment-resistant depression results in prolonged hospitalization and healthcare costs. Anti-inflammatory drugs...
12.
Mishra D, Shukla R
J Family Med Prim Care
. 2022 Nov;
11(7):3401-3406.
PMID: 36387677
The differential diagnosis of space-occupying lesion (SOL)s of adrenal gland is broad and ranges from benign to malignant. The diagnosis is important as management and prognosis differ widely. Increased use...
13.
Kasatwar A, Shukla R, Rathod N, Nandanwar J, Mishra D, Dhobley A
IJID Reg
. 2022 Aug;
5:21-29.
PMID: 36035237
Introduction: Coronavirus disease 2019 (COVID-19)-associated mucormycosis (CAM) became a public health problem in India in 2021. However, information about the incidence, presentation and prognosis of CAM remains sparse. Methods: This...
14.
Kumar Chandraker S, Lal M, Khanam F, Dhruve P, Singh R, Shukla R
Sci Rep
. 2022 May;
12(1):8831.
PMID: 35614187
Rubia cordifolia L. is a widely used traditional medicine in the Indian sub-continent and Eastern Asia. In the present study, the aqueous leaf extract of the R. Cordifolia was used...
15.
Tomo S, Sankanagoudar S, Shukla R, Sharma P
Ann Clin Biochem
. 2022 May;
59(6):454-456.
PMID: 35574637
No abstract available.
16.
Kumar Chandraker S, Lal M, Shukla R
RSC Adv
. 2022 May;
9(40):23408-23417.
PMID: 35514502
Green nanotechnology is gaining widespread interest owing to the elimination of harmful reagents and offers a cost-effective synthesis of expected products. In the present study, silver nanoparticles (AgNPs) were synthesized...
17.
Sankanagoudar S, Shukla R, Shukla K, Sharma P
Diabetes Metab Syndr
. 2022 Apr;
16(4):102481.
PMID: 35427914
Background And Aims: Over the past few years, branched-chain amino acids (BCAAs) are increasingly being linked to insulin resistance and type 2 diabetes mellitus (T2DM), but their relevance for metabolic...
18.
Tomo S, Sankanagoudar S, Shukla R, Sharma P
Diabetes Metab Syndr
. 2022 Mar;
16(4):102448.
PMID: 35313205
Background And Aims: LDL-cholesterol (LDL-C), being the primary predictor of cardiovascular disease in Type 2 diabetes (T2D), is associated with cardiovascular risk stratification and requires to be estimated with better...
19.
Ganakumar V, Jethwani P, Roy A, Shukla R, Mittal M, Garg M
Diabetes Metab Syndr
. 2021 Dec;
16(1):102371.
PMID: 34954484
SARS-CoV-2 pandemic has claimed millions of lives since its first identification in December 2019. Patients with diabetes are at a high risk of adverse outcomes after COVID-19 infection, whereas infection...
20.
Ahari K, Vijayan N, Garg M, Shukla R, Choudhary R
Natl Med J India
. 2021 Nov;
34(3):189-190.
PMID: 34825545
No abstract available.